Activest Wealth Management
CANF icon

Activest Wealth Management’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Activest Wealth Management’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22 Hold
10
– – ﹤0.01% 1042
2026
Q2 		$30 Hold
10
– – ﹤0.01% 1309
2026
Q1 		$31 Hold
10
– – ﹤0.01% 1193
2025
Q4 		$40 Hold
10
– – ﹤0.01% 1089
2025
Q3 		$124 Hold
10
– – ﹤0.01% 1049
2025
Q2 		$210 Hold
10
– – ﹤0.01% 944
2025
Q1 		$296 Hold
10
– – ﹤0.01% 912
2024
Q4 		$325 Hold
10
– – ﹤0.01% 583
2024
Q3 		$402 Hold
10
– – ﹤0.01% 494
2024
Q2 		$516 Buy
+10
New +$473 ﹤0.01% 459

Other funds holding CANF

GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Activest Wealth Management's CANF Position: Q3 2026 in Review

Activest Wealth Management held its Can-Fite BioPharma American Depositary Shares (CANF) position steady in Q3 2026 at 10 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #1042.

Activest Wealth Management first reported a position in CANF in Q2 2024 and has held it in 10 quarters since. The position peaked at $516 in Q2 2024. 5 funds tracked by Wall St. Rank hold CANF as of Q3 2026.

  • Activest Wealth Management held 10 shares of Can-Fite BioPharma American Depositary Shares worth $22 as of Q3 2026.
  • Activest Wealth Management left its Can-Fite BioPharma American Depositary Shares share count unchanged in Q3 2026.
  • Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #1042 holding.
  • Activest Wealth Management first reported a position in Can-Fite BioPharma American Depositary Shares in Q2 2024 and has held it in 10 quarters since.
  • Activest Wealth Management's Can-Fite BioPharma American Depositary Shares position peaked at $516 in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.